Pinkerton Retirement Specialists’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,247
Closed -$2.17M 137
2024
Q4
$2.17M Buy
25,247
+317
+1% +$34.3K 0.32% 74
2024
Q3
$2.97M Buy
24,930
+367
+1% +$48.9K 0.43% 63
2024
Q2
$3.51M Sell
24,563
-157
-0.6% -$20.8K 0.54% 57
2024
Q1
$3.17M Sell
24,720
-790
-3% -$94K 0.51% 58
2023
Q4
$2.64M Sell
25,510
-2,756
-10% -$273K 0.51% 47
2023
Q3
$2.57M Buy
28,266
+1,424
+5% +$125K 0.56% 47
2023
Q2
$2.17M Sell
26,842
-670
-2% -$54.7K 0.43% 67
2023
Q1
$2.19M Buy
+27,512
New +$1.95M 0.41% 68
2017
Q1
Sell
-15,908
Closed -$285K 382
2016
Q4
$285K Sell
15,908
-962
-6% -$17.4K 0.13% 72
2016
Q3
$351K Buy
16,870
+3,346
+25% +$83K 0.15% 87
2016
Q2
$364K Buy
+13,524
New +$371K 0.18% 63

Other funds holding NVO